These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 7718614
1. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Eriksson H, Ridderstråle M, Degerman E, Ekholm D, Smith CJ, Manganiello VC, Belfrage P, Tornqvist H. Biochim Biophys Acta; 1995 Apr 06; 1266(1):101-7. PubMed ID: 7718614 [Abstract] [Full Text] [Related]
4. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Zmuda-Trzebiatowska E, Oknianska A, Manganiello V, Degerman E. Cell Signal; 2006 Mar 06; 18(3):382-90. PubMed ID: 15961276 [Abstract] [Full Text] [Related]
5. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation. Smith CJ, Vasta V, Degerman E, Belfrage P, Manganiello VC. J Biol Chem; 1991 Jul 15; 266(20):13385-90. PubMed ID: 1649189 [Abstract] [Full Text] [Related]
7. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation. Elks ML, Manganiello VC. Endocrinology; 1985 May 15; 116(5):2119-21. PubMed ID: 2985373 [Abstract] [Full Text] [Related]
8. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Zhou L, Wang X, Yang Y, Wu L, Li F, Zhang R, Yuan G, Wang N, Chen M, Ning G. Biochim Biophys Acta; 2011 Apr 15; 1812(4):527-35. PubMed ID: 20969954 [Abstract] [Full Text] [Related]
9. Hormonal activation of the cGMP-inhibited low-Km cyclic AMP phosphodiesterase of rat adipocytes from different sites: influence of ovariectomy. Lacasa D, Agli B, Giudicelli Y. Biochim Biophys Acta; 1992 Jul 22; 1136(1):99-104. PubMed ID: 1322710 [Abstract] [Full Text] [Related]
10. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis. Omar B, Zmuda-Trzebiatowska E, Manganiello V, Göransson O, Degerman E. Cell Signal; 2009 May 22; 21(5):760-6. PubMed ID: 19167487 [Abstract] [Full Text] [Related]
11. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Elks ML, Manganiello VC. Endocrinology; 1984 Oct 22; 115(4):1262-8. PubMed ID: 6207009 [Abstract] [Full Text] [Related]
13. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes. Smith CJ, Manganiello VC. Mol Pharmacol; 1989 Mar 22; 35(3):381-6. PubMed ID: 2538713 [Abstract] [Full Text] [Related]
18. The cGMP-inhibitable phosphodiesterase modulates glucose transport activation by insulin. Eriksson JW, Wesslau C, Smith U. Biochim Biophys Acta; 1994 Jan 19; 1189(2):163-7. PubMed ID: 8292620 [Abstract] [Full Text] [Related]
20. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Müller G, Wied S, Over S, Frick W. Biochemistry; 2008 Feb 05; 47(5):1259-73. PubMed ID: 18186616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]